Genome-Wide Association Studies and Prediction of Normal Tissue Toxicity

Seminars in Radiation Oncology

Volumn 22, Issue 2, 2012, Pages 91-99

  West, Catharine M L ^a   Dunning, Alison M ^b   Rosenstein, Barry S ^c,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; CARCINOGENESIS; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE; HERITABILITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION INJURY; RADIOSENSITIVITY; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; RISK FACTORS;

EID: 84857565239     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2011.12.007     Document Type: Review

References (44)

1. Alsner J., Andreassen C.N., Overgaard J. Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol 2008, 18:126-135.
2. Andreassen C.N., Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: A systematic review. Radiother Oncol 2009, 92:299-309.
3. Barnett G.C., West C.M., Dunning A.M., et al. Normal tissue reactions to radiotherapy: Towards tailoring treatment dose by genotype. Nat Rev Cancer 2009, 9:134-142.
4. Rosenstein B.S. Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. Pharmacogenomics 2011, 12:267-275.
5. Kerns S.L., Ostrer H., Stock R., et al. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010, 78:1292-1300.
6. Altshuler D.M., Gibbs R.A., Peltonen L., et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010, 467:52-58.
7. Speliotes E.K., Willer C.J., Berndt S.I., et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2011, 42:937-948.
8. Lango Allen H., Estrada K., Lettre G., et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467:832-838.
9. Broeks A., Schmidt M.K., Sherman M.E., et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: Findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011, 20:3289-3303.
10. McCarthy M.I., Abecasis G.R., Cardon L.R., et al. Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet 2008, 9:356-369.
11. Curwen G.B., Cadwell K.K., Winther J.F., et al. The heritability of G2 chromosomal radiosensitivity and its association with cancer in Danish cancer survivors and their offspring. Int J Radiat Biol 2010, 86:986-995.
12. Curwen G.B., Winther J.F., Tawn E.J., et al. G(2) chromosomal radiosensitivity in Danish survivors of childhood and adolescent cancer and their offspring. Br J Cancer 2005, 93:1038-1045.
13. Finnon P., Robertson N., Dziwura S., et al. Evidence for significant heritability of apoptotic and cell cycle responses to ionising radiation. Hum Genet 2008, 123:485-493.
14. Roberts S.A., Spreadborough A.R., Bulman B., et al. Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer?. Am J Hum Genet 1999, 65:784-794.
15. Schmitz A., Bayer J., Dechamps N., et al. Heritability of susceptibility to ionizing radiation-induced apoptosis of human lymphocyte subpopulations. Int J Radiat Oncol Biol Phys 2007, 68:1169-1177.
16. Surowy H., Rinckleb A., Luedeke M., et al. Heritability of baseline and induced micronucleus frequencies. Mutagenesis 2011, 26:111-117.
17. Wu X., Spitz M.R., Amos C.I., et al. Mutagen sensitivity has high heritability: Evidence from a twin study. Cancer Res 2006, 66:5993-5996.
18. Safwat A., Bentzen S.M., Turesson I., et al. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys 2002, 52:198-204.
19. Yang J., Benyamin B., McEvoy B.P., et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010, 42:565-569.
20. Manolio T.A., Collins F.S., Cox N.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
21. O'Driscoll M., Gennery A.R., Seidel J., et al. An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst) 2004, 3:1227-1235.
22. Pollard J.M., Gatti R.A. Clinical radiation sensitivity with DNA repair disorders: An overview. Int J Radiat Oncol Biol Phys 2009, 74:1323-1331.
23. Taylor A.M., Harnden D.G., Arlett C.F., et al. Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity. Nature 1975, 258:427-429.
24. Stewart G.S., Maser R.S., Stankovic T., et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 1999, 99:577-587.
25. West C.M., Rosenstein B. Genetics and genomics of radiotherapy toxicity: Towards prediction. Genet Med 2011, 3:52.
26. Andreassen C.N., Alsner J., Overgaard M., et al. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM-A study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol 2006, 82:577-586.
27. Barnett G.C., Coles C.E., Burnet N.G., et al. No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: Results from the RAPPER study. Radiother Oncol 2010, 97:9-14.
28. Chanock S.J., Manolio T., Boehnke M., et al. Replicating genotype-phenotype associations. Nature 2007, 447:655-660.
29. Rosenberg N.A., Huang L., Jewett E.M., et al. Genome-wide association studies in diverse populations. Nat Rev Genet 2010, 11:356-366.
30. Torgerson D.G., Ampleford E.J., Chiu G.Y., et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011, 43:887-892.
31. Best T., Li D., Skol A.D., et al. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat Med 2011, 17:941-943.
32. Morton L.M., Chanock S.J. A step toward slaying the hydra of second cancers. Nat Med 2011, 17:924-925.
33. West C., Rosenstein B.S. Establishment of a radiogenomics consortium. Radiother Oncol 2010, 94:117-118.
34. West C., Rosenstein B.S., Alsner J., et al. Establishment of a Radiogenomics Consortium. Int J Radiat Oncol Biol Phys 2010, 76:1295-1296.
35. Ho K.F., Farnell D.J., Routledge J.A., et al. Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy. Radiother Oncol 2010, 97:270-275.
36. Trotti A., Pajak T.F., Gwede C.K., et al. TAME: Development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 2007, 8:613-624.
37. Barnett G.C., West C.M., Coles C.E., et al. Standardized total average toxicity score: A Scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies. Int J Radiat Oncol Biol Phys 2012, 82(3):1065-1074.
38. Jackson A., Marks L.B., Bentzen S.M., et al. The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys 2010, 76:S155-S160.
39. Spitz M.R., Amos C.I., Dong Q., et al. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 2008, 100:1552-1556.
40. Eifel P.J., Jhingran A., Bodurka D.C., et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 2000, 20:3651-3657.
41. Gibson G. Hints of hidden heritability in GWAS. Nat Genet 2010, 42:558-560.
42. Ashley E.A., Butte A.J., Wheeler M.T., et al. Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535.
43. Pharoah P.D., Antoniou A., Bobrow M., et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002, 31:33-36.
44. Pashayan N., Duffy S.W., Chowdhury S., et al. Polygenic susceptibility to prostate and breast cancer: Implications for personalised screening. Br J Cancer 2011, 104:1656-1663.